AV&H Represents URL/Mutual Companies in Launch of Guaifenesin Products

Axinn, Veltrop & Harkrider LLP is representing the URL/Mutual Pharmaceutical Companies in connection with the launch of various products containing the active ingredient guaifenesin.  This representation includes the defense of Hatch-Waxman patent litigation filed by Adams Respiratory Therapeutics, Inc. in both New Jersey and Pennsylvania in October 2006.  AV&H successfully opposed Adams’ efforts to stay the Pennsylvania proceedings, and trial is currently scheduled for April 2007.  In addition, AV&H filed antitrust and other counterclaims against Adams, alleging that Adams filed these baseless actions for the purpose of delaying FDA approval of its client’s guaifenesin products.